证券记录 · 已归档季度
OMCL
Omnicell, Inc. · Healthcare · Medical - Healthcare Information Services
18被追踪持有人
0Δ持有人
22.98M持有股份
$699.67M报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -1.5% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 51.82K | $1.76M | n/a | n/a |
| Q2 2026 | 98 | +2 | 36.92M | $1.52B | +8 | −7 |
| Q1 2026 | 100 | +1 | 36.98M | $1.23B | +6 | −5 |
| Q4 2025 | 99 | +2 | 40.13M | $1.82B | +2 | n/a |
| Q3 2025 | 18 | 0 | 22.98M | $699.67M | +1 | −1 |
| Q2 2025 | 15 | -1 | 21.34M | $627.32M | +1 | −2 |
| Q1 2025 | 13 | -1 | 6.74M | $235.79M | n/a | −1 |
| Q4 2024 | 14 | +1 | 6.20M | $275.97M | +1 | n/a |
| Q3 2024 | 12 | -1 | 3.89M | $169.70M | n/a | −1 |
| Q2 2024 | 13 | n/a | 3.69M | $99.83M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 7.66M | -2.3% | $233.11M | 0.0% | ▼ Trim | 2 | SEC ↗ ×16 |
| 2 | The Vanguard Group ✦ (被动) | 5.61M | -0.4% | $170.89M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (被动) | 2.05M | -2.0% | $62.44M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 1.14M | -19.7% | $34.78M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 5 | Geode Capital Management ✦ (被动) | 1.12M | -6.7% | $33.99M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | JPMorgan Chase ✦ | 1.03M | n/a | $31.38M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 7 | Millennium Management ✦ | 841.53K | 新增 | $25.62M | 0.0% | New | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 809.54K | +0.7% | $24.65M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 9 | Morgan Stanley ✦ | 585.36K | n/a | $17.82M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 10 | Two Sigma Investments ✦ | 559.97K | +93.8% | $17.05M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 11 | Goldman Sachs Group ✦ | 371.93K | n/a | $11.33M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | Citadel Advisors ✦ | 300.45K | -66.5% | $9.15M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 13 | Renaissance Technologies ✦ | 280.60K | -8.2% | $8.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 245.98K | +12.9% | $7.49M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 15 | Arrowstreet Capital ✦ | 189.61K | +31.3% | $5.77M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 75.94K | -77.2% | $2.31M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 57.45K | -36.5% | $1.75M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 18 | T. Rowe Price ✦ | 51.57K | +3.8% | $1.57M | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Millennium Management | $25.62M | 0.0% |
已清仓
| Gotham Asset Management | $735,441 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 2 持有人, 5.77M 股份, $5.60M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据